Beam Therapeutics Inc. (BEAM) Net margin 2019–2025
Beam Therapeutics Inc. (BEAM) net profit margin by fiscal year — reported net income divided by reported revenue.
-57.2%FY2025 · since FY2019: -435144.4% → -57.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -57.2% | +535.9 pp |
| FY2024 | -593.1% | -558.0 pp |
| FY2023 | -35.1% | +439.5 pp |
| FY2022 | -474.5% | +240.5 pp |
| FY2021 | -715.0% | +810085.0 pp |
| FY2020 | -810800.0% | -375655.6 pp |
| FY2019 | -435144.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice